This inventor holds 1 USPTO granted patent. Top assignee: The Medicines Company (Leipzig) Gmbh. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: The Innovations of Daniel Donnecke
Introduction
Daniel Donnecke is an accomplished inventor based in Victoria, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit tumor growth. His work is characterized by a focus on innovative chemical structures and their applications in medicine.
Latest Patents
One of Daniel Donnecke's notable patents is titled "Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors." This invention relates to meta-substituted phenyl sulfonyl amides of secondary amino acid amides, which are designed to inhibit matriptase. The patent highlights the potential use of these compounds as drugs for inhibiting tumor growth and metastasization. Daniel holds 1 patent in this area, showcasing his innovative approach to addressing critical health challenges.
Career Highlights
Daniel Donnecke is currently associated with The Medicines Company (Leipzig) GmbH, where he continues to advance his research and development efforts. His work at this organization allows him to collaborate with other experts in the field and contribute to the development of new therapeutic solutions.
Collaborations
Throughout his career, Daniel has worked alongside talented colleagues such as Torsten Steinmetzer and Andrea Schweinitz. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their shared field of research.
Conclusion
Daniel Donnecke's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts highlight his commitment to advancing medical science. His work continues to pave the way for new treatments that can significantly impact patient care.